Schedule & Agenda
2019 Schedule & Agenda
BIO Asia Webinar Series
11 Results
Tuesday, March 5
1:45 PM - 2:00 PM (JST)
VORONOI primarily develops small molecule inhibitors of kinases using kinase profiling and…
2nd Floor
2:00 PM - 2:15 PM (JST)
CanBas is aiming to find a cure for cancer patients. Its lead oncology drug candidate is a unique…
2nd Floor
2:15 PM - 2:30 PM (JST)
Omicsway is specialized on advanced bioinformatics of gene expression data. Our major area is…
2nd Floor
2:30 PM - 2:45 PM (JST)
Founded by 2 ex-Quintiles (Now IQVIA) and industry veterans, AUM Biosciences is an oncology-focused…
2nd Floor
3:00 PM - 3:15 PM (JST)
ACT Genomics is a leading Asia cancer molecular information company. We partner with biopharma to…
2nd Floor
Wednesday, March 6
8:30 AM - 8:45 AM (JST)
AIMM is a preclinical stage company in the process of advancing 2 antibodies into the clinic.
2nd Floor
8:45 AM - 9:00 AM (JST)
Kleo Pharmaceuticals is a unique immuno-oncology company developing next-generation bispecific…
2nd Floor
9:15 AM - 9:30 AM (JST)
BioInvent International AB (OMXS: BINV), is focused on the discovery and development of novel and…
2nd Floor
9:30 AM - 9:45 AM (JST)
AIVITA Biomedical is a clinical stage biotech developing next generation immunotherapies. We…
2nd Floor
9:45 AM - 10:00 AM (JST)
Cellerant Therapeutics is a clinical-stage biotech company focused on AML and other blood-related…
2nd Floor
10:00 AM - 10:15 AM (JST)
Delta-Fly has been focusing on oncology drug discovery and clinical development from hematologic…
2nd Floor
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
